Nexien Biopharma Stock Market Value
| NXEN Stock | USD 0.01 0.01 35.00% |
| Symbol | Nexien |
Nexien Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nexien Biopharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nexien Biopharma.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Nexien Biopharma on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Nexien Biopharma or generate 0.0% return on investment in Nexien Biopharma over 30 days. Nexien Biopharma is related to or competes with Cannara Biotech, Sonoma Pharmaceuticals, Aquestive Therapeutics, and Evoke Pharma. Nexien BioPharma, Inc. operates as a pharmaceutical company More
Nexien Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nexien Biopharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nexien Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 35.58 | |||
| Information Ratio | 0.1299 | |||
| Maximum Drawdown | 216.63 | |||
| Value At Risk | (47.71) | |||
| Potential Upside | 59.09 |
Nexien Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexien Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nexien Biopharma's standard deviation. In reality, there are many statistical measures that can use Nexien Biopharma historical prices to predict the future Nexien Biopharma's volatility.| Risk Adjusted Performance | 0.112 | |||
| Jensen Alpha | 4.17 | |||
| Total Risk Alpha | (0.84) | |||
| Sortino Ratio | 0.1269 | |||
| Treynor Ratio | 1.21 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nexien Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nexien Biopharma Backtested Returns
Nexien Biopharma is out of control given 3 months investment horizon. Nexien Biopharma has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13% return per unit of risk over the last 3 months. We were able to analyze and collect data for thirty different technical indicators, which can help you to evaluate if expected returns of 4.65% are justified by taking the suggested risk. Use Nexien Biopharma Mean Deviation of 20.42, risk adjusted performance of 0.112, and Downside Deviation of 35.58 to evaluate company specific risk that cannot be diversified away. Nexien Biopharma holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 3.83, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexien Biopharma will likely underperform. Use Nexien Biopharma semi variance, as well as the relationship between the daily balance of power and price action indicator , to analyze future returns on Nexien Biopharma.
Auto-correlation | 0.04 |
Virtually no predictability
Nexien Biopharma has virtually no predictability. Overlapping area represents the amount of predictability between Nexien Biopharma time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nexien Biopharma price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Nexien Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nexien Biopharma lagged returns against current returns
Autocorrelation, which is Nexien Biopharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nexien Biopharma's pink sheet expected returns. We can calculate the autocorrelation of Nexien Biopharma returns to help us make a trade decision. For example, suppose you find that Nexien Biopharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nexien Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nexien Biopharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nexien Biopharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nexien Biopharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Nexien Biopharma Lagged Returns
When evaluating Nexien Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nexien Biopharma pink sheet have on its future price. Nexien Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nexien Biopharma autocorrelation shows the relationship between Nexien Biopharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Nexien Biopharma.
Regressed Prices |
| Timeline |
Pair Trading with Nexien Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nexien Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexien Biopharma will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Nexien Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nexien Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nexien Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nexien Biopharma to buy it.
The correlation of Nexien Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nexien Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nexien Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nexien Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Nexien Pink Sheet
Nexien Biopharma financial ratios help investors to determine whether Nexien Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexien with respect to the benefits of owning Nexien Biopharma security.